Over $1 billion sat unused in US National Science Foundation (NSF) accounts as fiscal 2026 came to a close Oct. 1. A White ...

HydRegen’s scientists are commercializing hydrogenase systems that work in conventional chemical reactors. Credit: HydRegen Enzymes are powerful tools for chemical synthesis, but their natural setting ...

After successfully completing our previous strategic plan, we developed a new strategic plan in 2025. At its heart is our vision of “making chemistry accessible to all.” These are not simply words on ...

In a recent related study, researchers in China also developed a heterogeneous hydroformylation catalyst based on rhodium. The group also uses nitrogen-containing molecules to enhance catalytic ...

Biotechs in the US and Europe face challenges, but as a recent panel discussion made clear, the competition offers global ...

Finally, we should be worried about how these trial markets could impact public perception of the drug development and ...

Mary Jo Ondrechen, a distinguished professor of chemistry, says scientific fields are moving in an exciting direction ...

Estuary is now plotting human trials that will begin in 2027 and 2028. The first will test EST-201, a Pkd2 gene therapy for ...

One compound they screened, azo-morphine-3 (AM-3), showed high affinity and high potency for the μ-opioid receptor (MOR).

“Medicinal chemists are increasingly moving away from flat molecules towards rigid, three-dimensional shapes,” says Michael D ...

The US Department of Homeland Security (DHS) has proposed a new rule that would impose fees for international students ...

The American Chemical Society members elected the following officers and members of the ACS Board of Directors for 2027: ...